Metagenomi, Inc. financial data

Symbol
MGX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5959 Horton Street, 7 Th Floor, Emeryville, CA
Fiscal year end
December 31
Former names
Metagenomi Technologies, LLC (to 1/18/2024)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.4M shares
Common Stock, Shares, Outstanding 37.5M shares
Common Stock, Value, Issued 4K USD
Weighted Average Number of Shares Outstanding, Basic 36.6M shares +976%
Weighted Average Number of Shares Outstanding, Diluted 36.6M shares +976%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20M USD +76.5%
Research and Development Expense 28.3M USD +24.9%
General and Administrative Expense 8.55M USD +29.2%
Operating Income (Loss) -16.9M USD +6.12%
Nonoperating Income (Expense) 3.93M USD -42.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.9M USD -16.5%
Income Tax Expense (Benefit) -2.2M USD -216%
Net Income (Loss) Attributable to Parent -10.7M USD +17.4%
Earnings Per Share, Basic -0.29 USD/shares +92.4%
Earnings Per Share, Diluted -0.29 USD/shares +92.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 61.2M USD +18.5%
Cash, Cash Equivalents, and Short-term Investments 300M USD
Assets, Current 308M USD
Property, Plant and Equipment, Net 20.7M USD
Operating Lease, Right-of-Use Asset 41.4M USD
Other Assets, Noncurrent 332K USD
Assets 386M USD
Accounts Payable, Current 3.45M USD
Contract with Customer, Liability, Current 33M USD
Liabilities, Current 52.8M USD
Contract with Customer, Liability, Noncurrent 17.3M USD
Operating Lease, Liability, Noncurrent 42.5M USD
Other Liabilities, Noncurrent 3.8M USD
Liabilities 116M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -265K USD
Retained Earnings (Accumulated Deficit) -181M USD
Stockholders' Equity Attributable to Parent 269M USD
Liabilities and Equity 386M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.9M USD -42.2%
Net Cash Provided by (Used in) Financing Activities 86.5M USD +1915%
Net Cash Provided by (Used in) Investing Activities -94.7M USD -31.4%
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 37.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -38M USD +57.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.4M USD +16.8%
Depreciation 1.27M USD +51.4%
Payments to Acquire Property, Plant, and Equipment 915K USD -65.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.7M USD +18.6%
Operating Lease, Liability, Current 5.4M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 451M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.51M USD +588%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares